Inflammation modulates human HDL composition and function in vivo

Atherosclerosis, 05/25/2012

The data support the concept that “atherogenic–HDL dysfunction” and impaired reverse cholesterol transport (RCT) occur in human inflammatory syndromes, largely independent of changes in plasma HDL–C and ApoA–I levels.

Print Article Summary